Optinose to Present at the 2018 RBC Capital Markets Healthcare Conference
February 15, 2018 08:00 ET
|
OptiNose, Inc.
YARDLEY, Pa., Feb. 15, 2018 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced...
Optinose to Present at Leerink Partners 7th Annual Global Healthcare Conference
February 09, 2018 08:00 ET
|
OptiNose, Inc.
YARDLEY, Pa., Feb. 09, 2018 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced...
Optinose to Present at BMO Capital Markets Prescription for Success Healthcare Conference
December 07, 2017 16:05 ET
|
OptiNose, Inc.
YARDLEY, Pa., Dec. 07, 2017 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ENT and allergy specialists, today announced that Chief Executive...
Optinose to Present at Piper Jaffray Healthcare Conference
November 17, 2017 07:30 ET
|
OptiNose, Inc.
YARDLEY, Pa., Nov. 17, 2017 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ENT and allergy specialists, today announced that Chief Executive...
Optinose to Present at Jefferies 2017 London Healthcare Conference
November 08, 2017 08:00 ET
|
OptiNose, Inc.
YARDLEY, Pa., Nov. 08, 2017 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ENT and allergy specialists, today announced that Chief Executive...
Optinose Expands Leadership Team with Key Hires
October 30, 2017 08:00 ET
|
OptiNose, Inc.
YARDLEY, Pa., Oct. 30, 2017 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ENT and allergy specialists, today announced the addition of five key...
Optinose Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares of Common Stock
October 17, 2017 16:01 ET
|
OptiNose, Inc.
YARDLEY, Pa., Oct. 17, 2017 (GLOBE NEWSWIRE) -- OptiNose, Inc. (NASDAQ:OPTN), a specialty pharmaceutical company focused on the development and commercialization of products for patients treated by...